TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 88 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $0 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | 1,781,617 | $637,000 | 0.08% |
| Anson Funds Management LP | 864,322 | $309,000 | 0.03% |
| Virtu Financial LLC | 307,275 | $110,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 18,680,699 | $6,682,000 | 0.01% |
| Renaissance Technologies | 10,699,831 | $3,827,000 | 0.01% |
| Point72 Hong Kong Ltd | 348,383 | $125,000 | 0.00% |
| MONECO Advisors, LLC | 35,000 | $7,000 | 0.00% |
| Purus Wealth Management, LLC | 15,000 | $5,000 | 0.00% |
| PRUDENTIAL FINANCIAL INC | 6,929,345 | $2,479,000 | 0.00% |
| ALPS ADVISORS INC | 548,866 | $196,000 | 0.00% |